Polish patients with atopic dermatitis reported lower overall health and impaired quality of life related to mental health in the first year of the COVID-19 pandemic.
Nearly half of surveyed patients with atopic dermatitis (AD) were discontented with telemedicine during the COVID-19 pandemic, with lower overall health ratings and life satisfaction also reported by these populations. Findings were published in the International Journal of Environmental Research and Public Health.
As patients with AD are more prone to adverse behavioral health conditions such as anxiety and depression, preventive measures precipitated by the pandemic and the threat of COVID-19 infection may further exacerbate mental health and disease severity in patients, researchers hypothesized.
“Although SARS-CoV-2 is mainly responsible for respiratory disfunctions, not skin disorders, it has an immense impact on dermatology and dermatological patients,” they added. “A number of chronic skin diseases may be exacerbated by stress, toxic substances and allergens found in disinfectants and cleansers.”
Researchers sought to determine the impact of the COVID-19 pandemic on the mental state and exacerbation of skin lesions in patients with AD.
Adult patients with AD were recruited from the Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, at the Medical University of Lodz in Poland, and the Dermoklinika Centrum Medyczne. Participants completed surveys betwee May and August 2020 on their cognitive and preventive behaviors regarding COVID-19 and the accessibility of medical support, including online consultations.
Patients also responded to the self-reported Dermatology Life Quality Index (DLQI) and Hospital Anxiety and Depression Scale for anxiety (HADS-A) and depression (HADS-D).
A total of 138 patients completed the survey questionnaire (mean [SD] age, 32.04 [7.45] years; 54% male), of whom more than half (53.6%) were living in a large city (over 500,000 inhabitants). Five patients (3.6%) had relatives or friends diagnosed with COVID-19, and none were asked to quarantine due to suspicion of infection nor had they been infected.
According to survey findings, 69% of patients were worried about being infected with COVID-19, and 63% believed that people suffering from skin disease were more prone to be infected with the virus than the general population.
Reduced quality of life and greater severity of anxiety and depression was exhibited by patients with mild and moderate AD during the pandemic compared with before, but these trends were not statistically significant in those with severe disease:
Furthermore, 66.1% of the patients reported using telemedicine, of whom nearly 50% were discontented with its use. One-third of patients reported no issues with its use. Most patients (60%) who received immunosuppressive and immunomodulating treatments considered changing their treatment, and a total of 12% of patients temporarily interrupted their use of drugs during the pandemic.
“These results provide original information that can be applied in dermatologic patient screenings, as it is important to evaluate the state of depression and anxiety during the epidemic period,” concluded the study authors. “The identification of patients who are depressed and would benefit from further support is necessary in order to make individual interventions in time.”
Reference
Sieniawska J, Lesiak A, Ciążyński K, Narbutt J, and Ciążyńska M. Impact of the COVID-19 pandemic on atopic dermatitis patients. Int J Environ Res Public Health. 2022 Feb 2;19(3):1734. doi:10.3390/ijerph19031734
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
2 Commerce Drive
Cranbury, NJ 08512